Myocardial T1 mapping and extracellular volume quantification: A Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue 1, 2013, Pages

  Moon, James C ^a,b   Messroghli, Daniel R ^c   Kellman, Peter ^d   Piechnik, Stefan K ^e   Robson, Matthew D ^e   Ugander, Martin ^f   Gatehouse, Peter D ^g   Arai, Andrew E ^d   Friedrich, Matthias G ^h   Neubauer, Stefan ^e   Schulz Menger, Jeanette ^i,j   Schelbert, Erik B ^k  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g ROYAL BROMPTON HOSPITAL   (United Kingdom)

^h MONTREAL HEART INSTITUTE   (Canada)

ⁱ HUMBOLDT UNIVERSITY   (Germany)

^j HELIOS KLINIKUM BERLIN BUCH   (Germany)

^k UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL DECISION MAKING; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; INTERSTITIUM; ISCHEMIC CARDIOMYOPATHY; LIMIT OF QUANTITATION; MYOCARDIAL DISEASE; MYOCARDIAL T1 MAPPING; PRIORITY JOURNAL; QUALITY CONTROL; SUDDEN CARDIAC DEATH;

CONSENSUS; FIBROSIS; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS;

EID: 84885338673     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-15-92     Document Type: Article

References (89)

1. Moon JC, T1 mapping group minutes Available at: http://www.scmr.org/ forum/viewtopic.php?f=8&t=190&p=1344#p1344. Accessed June 22, 2013
2. T1 mapping in patients with acute myocardial infarction. Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG, J. Cardiovasc. Magn. Reson. 2003 5 353 59 (Pubitemid 36569954)
3. Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP, Magn. Reson. Med. 2004 52 141 46 (Pubitemid 39295266)
4. Distribution and kinetics of CoEDTA in smooth muscle, and its use as an extracellular marker. Brading AF, Jones AW, J. Physiol. 1969 200 387 401
5. Poole-Wilson PA, The intracellular pH, potassium and electrolyte content of heart muscle in acidosis and alkalosis London: University of Cambridge 1975
6. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Arheden H, Saeed M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R, Dae MW, Wendland MF, Radiology 1999 211 698 708 (Pubitemid 29249466)
7. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE, Am. J. Physiol. Heart Circ. Physiol. 2008 295 1234 42
8. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. Ugander M, Bagi PS, Oki AJ, Chen B, Hsu LY, Aletras AH, Shah S, Greiser A, Kellman P, Arai AE, JACC Cardiovasc. Imaging 2012 5 596 603
9. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Choudhury RP, Friedrich MG, Robson MD, Neubauer S, J. Cardiovasc. Magn. Reson. 2012 14 42
10. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC, JACC Cardiovasc. Imaging 2013 6 488 97
11. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, Francis JM, Karamitsos TD, Prendergast BD, Robson MD, Neubauer S, Moon JC, Myerson SG, Heart 2013 99 932 37
12. Identification and assessment of anderson-fabry disease by cardiovascular magnetic resonance noncontrast myocardial t1 mapping. Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC, Circ. Cardiovasc. Imaging 2013 6 392 98
13. Effect of tissue fat and water content on nuclear magnetic resonance relaxation times of cardiac and skeletal muscle. Scholz TD, Fleagle SR, Parrish FC, Breon T, Skorton DJ, Magn. Reson. Imaging 1990 8 605 11 (Pubitemid 20321977)
14. Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction. Pedersen SF, Thrysoe SA, Robich MP, Paaske WP, Ringgaard S, Botker HE, Hansen ES, Kim WY, J. Cardiovasc. Magn. Reson. 2012 14 59
15. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Puntmann VO, D'Cruz D, Smith Z, Pastor A, Choong P, Voigt T, Carr-White G, Sangle S, Schaeffter T, Nagel E, Circ. Cardiovasc. Imaging 2013 6 295 301
16. The identification and assessment of Anderson Fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping. Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC, Circ. Cardiovasc. Imaging 2013 6 392 8
17. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. Dall'Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM, Cuculi F, Kharbanda RK, Banning AP, Choudhury RP, Karamitsos TD, Neubauer S, J. Cardiovasc. Magn. Reson. 2012 14 15
18. T mapping for the diagnosis of acute myocarditis using CMR: comparison to T-weighted and late gadolinium enhanced imaging. Ferreira VM, Piechnik SK, Dall'armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S, JACC Cardiovasc Imaging 2013 doi:10.1016/j.jcmg.2013.03.008 [Epud ahead of print]
19. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Weber KT, Brilla CG, Circulation 1991 83 1849 65
20. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB, Circulation 2012 126 1206 16
21. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Wong TC, Piehler K, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH, Schelbert EB, Eur. Heart J. 2013 doi: 10.1093/eurheartj/eht193
22. Strategies and opportunities for drug development in heart failure. Butler J, Fonarow GC, Gheorghiade M, JAMA 2013 309 1593 94
23. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Banypersad SM, Sado DM, Flett AS, Gibbs SDJ, Pinney JH, Maestrini V, Cox AT, Fontana M, Whelan CJ, Wechalekar AD, Hawkins PN, Moon JC, Circ. Cardiovasc. Imaging 2012 6 34 9
24. Comparison of T1 mapping techniques for ECV quantification: histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. Fontana M, White SK, Banypersad SM, Sado DM, Maestrini V, Flett AS, Piechnik SK, Neubauer S, Roberts N, Moon JC, J. Cardiovasc. Magn. Reson. 2012 14 88
25. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Brilla CG, Funck RC, Rupp H, Circulation 2000 102 1388 93
26. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago JL, Circulation 2002 105 2512 17 (Pubitemid 34568973)
27. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Izawa H, Murohara T, Nagata K, Isobe S, Asano H, Amano T, Ichihara S, Kato T, Ohshima S, Murase Y, Iino S, Obata K, Noda A, Okumura K, Yokota M, Circulation 2005 112 2940 45 (Pubitemid 41612295)
28. Ventricular arrhythmias in hypertensive left ventricular hypertrophy: relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. McLenachan JM, Dargie HJ, Am. J. Hypertens. 1990 3 735 40 (Pubitemid 20345997)
29. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC, Hauer RN, Kirkels H, Janse MJ, De Bakker JM, Circulation 2001 104 3069 75 (Pubitemid 34014059)
30. Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. Anderson KP, Walker R, Urie P, Ershler PR, Lux RL, Karwandee SV, J. Clin. Invest. 1993 92 122 40 (Pubitemid 23208988)
31. Vulnerable myocardial interstitium in patients with isolated left ventricular hypertrophy and sudden cardiac death: a postmortem histological evaluation. Tamarappoo BK, John BT, Reinier K, Teodorescu C, Uy-Evanado A, Gunson K, Jui J, Chugh SS, J Am Heart Assoc. 2012 1 001511
32. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Schwartzkopff B, Brehm M, Mundhenke M, Strauer BE, Hypertension 2000 36 220 25 (Pubitemid 30626992)
33. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, De Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, et al. Circulation 2003 108 1664 72 (Pubitemid 37243650)
34. Diabetic cardiomyopathy-a distinct disease? Khavandi K, Khavandi A, Asghar O, Greenstein A, Withers S, Heagerty AM, Malik RA, Best Pract. Res. Clin. Endocrinol. Metab. 2009 23 347 60
35. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. Asbun J, Villarreal FJ, J. Am. Coll. Cardiol. 2006 47 693 700 (Pubitemid 43243087)
36. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Goser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, Zittrich S, Blaudeck N, Hardt SE, Pfitzer G, Rose NR, Katus HA, Kaya Z, Circulation 2006 114 1693 702 (Pubitemid 44607117)
37. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Van Hoeven KH, Factor SM, Circulation 1990 82 848 55 (Pubitemid 20316736)
38. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Wynn TA, Ramalingam TR, Nat. Med. 2012 18 1028 40
39. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P, Circulation 1994 89 151 63 (Pubitemid 24026485)
40. The cellular basis of dilated cardiomyopathy in humans. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, Anversa P, J. Mol. Cell. Cardiol. 1995 27 291 305
41. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ, Gudnason V, Harris TB, Arai AE, JAMA 2012 308 890 96
42. Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography. Wong TC, Piehler K, Puntil KS, Moguillansky D, Meier CG, Lacomis JL, Kellman P, Cook SC, Schwartzman DS, Simon MA, Mulukutla SR, Schelbert EB, J. Cardiovasc. Magn. Reson. 2013 15 1
43. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA, Lee VV, Flamm SD, Circulation 2009 120 2069 76
44. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international multicenter study. Klem I, Shah DJ, White RD, Pennell DJ, Van Rossum AC, Regenfus M, Sechtem U, Schvartzman PR, Hunold P, Croisille P, Parker M, Judd RM, Kim RJ, Circ. Cardiovasc. Imaging 2011 4 610 19
45. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM, N. Engl. J. Med. 2000 343 1445 53
46. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown TD, Ismail NA, Dweck MR, Di Pietro E, Roughton M, Wage R, Daryani Y, O'Hanlon R, Sheppard MN, Alpendurada F, Lyon AR, Cook SA, Cowie MR, Assomull RG, Pennell DJ, Prasad SK, JAMA 2013 309 896 908
47. Impact of early vs. Late microvascular obstruction assessed by magnetic resonance imaging on long-Term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. De Waha S, Desch S, Eitel I, Fuernau G, Zachrau J, Leuschner A, Gutberlet M, Schuler G, Thiele H, Eur. Heart J. 2010 31 2660 68
48. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA, McKenna WJ, Taylor AM, Hausenloy DJ, Hawkins PN, Elliott PM, Moon JC, Heart 2012 98 1436 41
49. Extracellular volume fraction mapping in the myocardium, Part 2: initial clinical experience. Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, Arai AE, J. Cardiovasc. Magn. Reson. 2012 14 64
50. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M, Circ. Cardiovasc. Imaging 2010 3 727 34
51. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, Sibley CT, Chen MY, Bandettini WP, Arai AE, Eur. Heart J. 2012 33 1268 78
52. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Flett AS, Sado DM, Quarta G, Mirabel M, Pellerin D, Herrey AS, Hausenloy DJ, Ariti C, Yap J, Kolvekar S, Taylor AM, Moon JC, Eur Heart J Cardiovasc Imaging. 2012 13 819 26
53. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY, JACC Cardiovasc. Imaging 2012 5 897 907
54. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC, Circulation 2010 122 138 44
55. Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy. Schalla S, Bekkers SC, Dennert R, Van Suylen RJ, Waltenberger J, Leiner T, Wildberger J, Crijns HJ, Heymans S, Eur. J. Heart Fail. 2010 12 227 31
56. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. Schelbert EB, Testa SM, Meier CG, Ceyrolles WJ, Levenson JE, Blair AJ, Kellman P, Jones BL, Ludwig DR, Schwartzman D, Shroff SG, Wong TC, J. Cardiovasc. Magn. Reson. 2011 13 16
57. Myocardial tissue remodeling in adolescent obesity. Shah RV, Abbasi SA, Neilan TG, Hulten E, Coelho-Filho O, Hoppin A, Levitsky L, De Ferranti S, Rhodes ET, Traum A, Goodman E, Feng H, Heydari B, Harris WS, Hoefner DM, McConnell JP, Seethamraju R, Rickers C, Kwong RY, Jerosch-Herold M, J Am Heart Assoc. 2013 2 000279
58. Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling. Tham EB, Haykowsky MJ, Chow K, Spavor M, Kaneko S, Khoo NS, Pagano JJ, Mackie AS, Thompson RB, J. Cardiovasc. Magn. Reson. 2013 15 48
59. Extracellular volume fraction mapping in the myocardium, Part 1: evaluation of an automated method. Kellman P, Wilson JR, Xue H, Ugander M, Arai AE, J. Cardiovasc. Magn. Reson. 2012 14 63
60. High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy. Tyralla K, Adamczak M, Benz K, Campean V, Gross ML, Hilgers KF, Ritz E, Amann K, PLoS One 2011 6 15287
61. Ageing of the heart. Roffe C, Br. J. Biomed. Sci. 1998 55 136 48 (Pubitemid 28356591)
62. Reversal of experimental renovascular hypertension restores coronary microvascular function and architecture. Urbieta-Caceres VH, Zhu XY, Gibson ME, Favreau FD, Jordan K, Lerman A, Lerman LO, Am. J. Hypertens. 2011 24 458 65
63. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Miller CA, Naish J, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJ, Schmitt M, Circ Cardiovasc Imaging 2013 6 373 83
64. Histopathological types of cardiac fibrosis in myocardial disease. Anderson KR, Sutton MG, Lie JT, J. Pathol. 1979 128 79 85 (Pubitemid 10226200)
65. Molecular mechanisms of myocardial remodeling. Swynghedauw B, Physiol. Rev. 1999 79 215 62 (Pubitemid 29056953)
66. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, Piechnik SK, Robson MD, Hausenloy DJ, Sheikh AM, Hawkins PN, Moon JC, JACC Cardiovasc. Imaging 2013 doi: 10.1016/j.jcmg.2013.01. 011
67. T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision. Kellman P, Arai AE, Xue H, J. Cardiovasc. Magn. Reson. 2013 15 56
68. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, De Vet HC, BMJ 2003 326 41 4 (Pubitemid 36110721)
69. T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S, Magn Reson Med 2013 doi:10.1002/mrm.24867 [Epub ahead of print]
70. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, J. Am. Coll. Cardiol. 2008 52 1574 80
71. T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Sibley CT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB, Mudd JO, van der Geest RJ, Lima JA, Halushka MK, Bluemke DA, Radiology 2012 265 724 32
72. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA, J. Cardiovasc. Magn. Reson. 2012 14 26
73. On flow effects in balanced steady-state free precession imaging: pictorial description, parameter dependence, and clinical implications. Markl M, Pelc NJ, J. Magn. Reson. Imaging 2004 20 697 705 (Pubitemid 39313747)
74. Influence of off-resonance in myocardial T1-mapping using SSFP based MOLLI method. Kellman P, Herzka DA, Arai AE, Hansen MS, J. Cardiovasc. Magn. Reson. 2013 15 63
75. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. Hunold P, Schlosser T, Vogt FM, Eggebrecht H, Schmermund A, Bruder O, Schuler WO, Barkhausen J, AJR Am. J. Roentgenol. 2005 184 1420 26 (Pubitemid 43821809)
76. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ, Eur. Heart J. 2005 26 1461 74 (Pubitemid 41373486)
77. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, Muthurangu V, Moon JC, JACC Cardiovasc. Imaging 2011 4 150 56
78. Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: effects of transcytolemmal water exchange. Zhou R, Pickup S, Yankeelov TE, Springer CS Jr, Glickson JD, Magn. Reson. Med. 2004 52 248 57 (Pubitemid 39025268)
79. Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo. Landis CS, Li X, Telang FW, Molina PE, Palyka I, Vetek G, Springer CS Jr, Magn. Reson. Med. 1999 42 467 78 (Pubitemid 29416208)
80. The role of transcytolemmal water exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Coelho-Filho OR, Mongeon FP, Mitchell R, Moreno H Jr, Nadruz W Jr, Kwong R, Jerosch-Herold M, Circ Cardiovasc Imaging 2013 134 41
81. Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution-reproducibility study. Messroghli DR, Plein S, Higgins DM, Walters K, Jones TR, Ridgway JP, Sivananthan MU, Radiology 2006 238 1004 12 (Pubitemid 43289933)
82. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J, J. Magn. Reson. Imaging 2007 26 1081 86 (Pubitemid 47548170)
83. Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD, J. Cardiovasc. Magn. Reson. 2010 12 69
84. Saturation recovery single-shot acquisition (SASHA) for myocardial T mapping. Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB, Magn Reson Med 2013 doi:10.1002/mrm.24878 [Epud ahead of print]
85. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NA, Banerjee R, Holloway C, Hofman MB, Sado DM, Maestrini V, White SK, Lazdam M, Karamitsos T, Moon JC, Neubauer S, Leeson P, Robson MD, J. Cardiovasc. Magn. Reson. 2013 15 13
86. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Coelho-Filho OR, Mongeon FP, Mitchell R, Moreno H Jr, Nadruz W Jr, Kwong R, Jerosch-Herold M, Circ. Cardiovasc. Imaging 2013 6 134 41
87. Novel imaging techniques for diffuse myocardial fibrosis. Sado DM, Flett AS, Moon JC, Future Cardiol. 2011 7 643 50
88. Measuring myocardial scar by CMR. Kwong RY, Farzaneh-Far A, JACC Cardiovasc. Imaging 2011 4 157 60
89. Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. Nacif MS, Kawel N, Lee JJ, Chen X, Yao J, Zavodni A, Sibley CT, Lima JA, Liu S, Bluemke DA, Radiology 2012 264 876 83